Amoeba (XPAR:ALMIB) Additional Paid-In Capital : €13.12 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Amoeba Additional Paid-In Capital?

Amoeba's quarterly additional paid-in capital declined from Dec. 2022 (€17.41 Mil) to Jun. 2023 (€13.12 Mil) but then stayed the same from Jun. 2023 (€13.12 Mil) to Dec. 2023 (€13.12 Mil).

Amoeba's annual additional paid-in capital declined from Dec. 2021 (€45.83 Mil) to Dec. 2022 (€17.41 Mil) and declined from Dec. 2022 (€17.41 Mil) to Dec. 2023 (€13.12 Mil).

Amoeba Additional Paid-In Capital Historical Data

The historical data trend for Amoeba's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoeba Additional Paid-In Capital Chart

Amoeba Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

35.07

40.62

45.83

17.41

13.12

Amoeba Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															45.83	9.83	17.41	13.12	13.12

Amoeba Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Amoeba Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Amoeba's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoeba (XPAR:ALMIB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Amoeba SA (XPAR:ALMIB) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

A1H:Germany

Address

38 Avenue des Freres Montgolfier, Chassieu, Lyon, FRA, 69680

Website

http://www.amoeba-biocide.com

Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.

Amoeba (XPAR:ALMIB) Headlines

No Headlines